Identification of tumor-regression antigens in melanoma.
Kawakami
Y
Y
Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA.
Robbins
P F
PF
Wang
R F
RF
Rosenberg
S A
SA
D000595:Amino Acid Sequence; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D015551:Autoimmunity; D019070:Cell Lineage; D003602:Cytotoxicity, Immunologic; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D008544:Melanocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology*; D009363:Neoplasm Proteins / Q000276:immunology; D017634:Self Tolerance; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D014820:Vitiligo / Q000209:etiology
D000951:Antigens, Neoplasm; D006680:HLA Antigens; D007155:Immunologic Factors; D007376:Interleukin-2; D009363:Neoplasm Proteins